Great Lakes Advisors LLC Has $10.86 Million Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Great Lakes Advisors LLC grew its position in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 113.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 139,116 shares of the company’s stock after buying an additional 74,016 shares during the period. Great Lakes Advisors LLC’s holdings in Prestige Consumer Healthcare were worth $10,864,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. HighTower Advisors LLC grew its holdings in shares of Prestige Consumer Healthcare by 89.5% in the 4th quarter. HighTower Advisors LLC now owns 31,666 shares of the company’s stock valued at $2,473,000 after buying an additional 14,958 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Prestige Consumer Healthcare by 7.1% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 11,053 shares of the company’s stock valued at $863,000 after buying an additional 731 shares during the period. Amundi lifted its position in Prestige Consumer Healthcare by 187.4% in the 4th quarter. Amundi now owns 25,669 shares of the company’s stock valued at $1,909,000 after acquiring an additional 16,737 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in Prestige Consumer Healthcare by 5.9% in the 4th quarter. PNC Financial Services Group Inc. now owns 5,276 shares of the company’s stock valued at $412,000 after acquiring an additional 296 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new stake in Prestige Consumer Healthcare in the 4th quarter valued at $42,593,000. Institutional investors and hedge funds own 99.95% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently commented on PBH. Canaccord Genuity Group boosted their price objective on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a research report on Friday, February 7th. Oppenheimer boosted their price objective on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a research report on Thursday, February 13th. Raymond James raised shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research report on Thursday, December 19th. Sidoti cut shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective on the stock. in a research report on Monday, December 9th. Finally, StockNews.com cut shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research report on Monday. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $92.60.

Insiders Place Their Bets

In other news, SVP Mary Beth Fritz sold 1,678 shares of the business’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $90.00, for a total transaction of $151,020.00. Following the transaction, the senior vice president now directly owns 17,157 shares in the company, valued at $1,544,130. The trade was a 8.91 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 1.60% of the company’s stock.

Prestige Consumer Healthcare Trading Down 2.7 %

Shares of NYSE:PBH opened at $82.83 on Thursday. The company’s 50-day moving average price is $81.22 and its two-hundred day moving average price is $78.12. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20. Prestige Consumer Healthcare Inc. has a one year low of $62.35 and a one year high of $90.04. The stock has a market capitalization of $4.10 billion, a PE ratio of 19.40, a price-to-earnings-growth ratio of 2.69 and a beta of 0.46.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, February 6th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. On average, equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.